Works by Chen, Lin-Chi


Results: 22
    1
    2
    3
    4
    5
    6
    7
    9
    10
    11
    12
    13
    14

    MDM2 antagonist clinical response association with a gene expression signature in acute myeloid leukaemia.

    Published in:
    British Journal of Haematology, 2015, v. 171, n. 3, p. 432, doi. 10.1111/bjh.13411
    By:
    • Zhong, Hua;
    • Chen, Gong;
    • Jukofsky, Lori;
    • Geho, David;
    • Han, Sung Won;
    • Birzele, Fabian;
    • Bader, Sabine;
    • Himmelein, Lucia;
    • Cai, James;
    • Albertyn, Zayed;
    • Rothe, Mark;
    • Essioux, Laurent;
    • Burtscher, Helmut;
    • Middleton, Steven A.;
    • Rueger, Ruediger;
    • Chen, Lin‐Chi;
    • Dangl, Markus;
    • Nichols, Gwen;
    • Pierceall, William E.
    Publication type:
    Article
    15
    16
    17
    18
    19
    20

    Phase I study of daily and weekly regimens of the orally administered MDM2 antagonist idasanutlin in patients with advanced tumors.

    Published in:
    Investigational New Drugs, 2021, v. 39, n. 6, p. 1587, doi. 10.1007/s10637-021-01141-2
    By:
    • Italiano, Antoine;
    • Miller Jr, Wilson H.;
    • Blay, Jean-Yves;
    • Gietema, Jourik A.;
    • Bang, Yung-Jue;
    • Mileshkin, Linda R.;
    • Hirte, Hal W.;
    • Higgins, Brian;
    • Blotner, Steven;
    • Nichols, Gwen L.;
    • Chen, Lin Chi;
    • Petry, Claire;
    • Yang, Qi Joy;
    • Schmitt, Christophe;
    • Jamois, Candice;
    • Siu, Lillian L.
    Publication type:
    Article
    21
    22